Listed

Kraig Biocraft Laboratories, Inc.: Form 10-Q for the period ended Sep 30, 2012

Filed with the SEC on Nov 19, 2012 and accepted by EDGAR at Nov 19, 2012, 16:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2012-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2012-07-01 to 2012-09-30$0us-gaap:SalesRevenueNet
Revenue9 months2012-01-01 to 2012-09-30$0us-gaap:SalesRevenueNet
Research and development3 months2012-07-01 to 2012-09-30$145.4kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2012-01-01 to 2012-09-30$355.4kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2012-07-01 to 2012-09-30−$276.9kus-gaap:OperatingIncomeLoss
Operating income9 months2012-01-01 to 2012-09-30−$901.8kus-gaap:OperatingIncomeLoss
Interest expense3 months2012-07-01 to 2012-09-30$15.6kus-gaap:InterestExpense
Interest expense9 months2012-01-01 to 2012-09-30$45.7kus-gaap:InterestExpense
Income tax3 months2012-07-01 to 2012-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2012-01-01 to 2012-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2012-07-01 to 2012-09-30−$292.5kus-gaap:NetIncomeLoss
Net income9 months2012-01-01 to 2012-09-30−$944.4kus-gaap:NetIncomeLoss
Diluted EPS3 months2012-07-01 to 2012-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2012-01-01 to 2012-09-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2012-01-01 to 2012-09-30−$456.1kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2012-01-01 to 2012-09-30$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2012-09-30$136.3kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2012-09-30$143.5kus-gaap:AssetsCurrent
Total assetsAt period end2012-09-30$161.4kus-gaap:Assets
Current liabilitiesAt period end2012-09-30$1.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2012-09-30$1.1mus-gaap:Liabilities
Shareholders' equityAt period end2012-09-30−$940.9kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001354488-12-006043. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.